Order Article Reprints

Udompornpitak K, Bhunyakarnjanarat T, Saisorn W, Manipuntee C, Plengplang K, Sittichaitaweekul S, Jenphatanapong P, Udomkarnjananun S, Kaewduangduen W, Ariya-anandech K, et al. Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy. Pharmaceutics. 2023; 15(12):2695. https://doi.org/10.3390/pharmaceutics15122695

Udompornpitak, Kanyarat, Thansita Bhunyakarnjanarat, Wilasinee Saisorn, Chonnavee Manipuntee, Kittawat Plengplang, Samarch Sittichaitaweekul, Panisa Jenphatanapong, Suwasin Udomkarnjananun, Warerat Kaewduangduen, Kasirapat Ariya-anandech, and et al. 2023. "Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy" Pharmaceutics 15, no. 12: 2695. https://doi.org/10.3390/pharmaceutics15122695

Udompornpitak, K., Bhunyakarnjanarat, T., Saisorn, W., Manipuntee, C., Plengplang, K., Sittichaitaweekul, S., Jenphatanapong, P., Udomkarnjananun, S., Kaewduangduen, W., Ariya-anandech, K., Samaeng, A., Insin, N., Ritprajak, P., & Leelahavanichkul, A. (2023). Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy. Pharmaceutics, 15(12), 2695. https://doi.org/10.3390/pharmaceutics15122695